AL
Arlinda Lee Canaccord Genuity Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Delcath Systems
DCTH
$404M
| $11.60 | $21 |
81%
upside
| Buy |
7 Sep ‘23
2 years ago |
|
2
X4 Pharmaceuticals
XFOR
$76.1M
| $3.28 | $300 |
9,046%
upside
| Buy |
5 Apr ‘22
3 years ago |
|
3
Nektar Therapeutics
NKTR
$843M
| $48.57 | $90 |
85%
upside
| Buy |
16 Mar ‘22
3 years ago |
|
4
Rhythm Pharmaceuticals
RYTM
$6.63B
| $101.44 | $36 |
65%
downside
| Buy |
7 Mar ‘22
3 years ago |
|
5
Celcuity
CELC
$2.65B
| $60.77 | $50 |
18%
downside
| Buy |
8 Oct ‘21
3 years ago |
|
6
CRISPR Therapeutics
CRSP
$4.92B
| $53.69 | $160 |
198%
upside
| Buy |
16 Aug ‘21
4 years ago |
|
|
BCYC
7
Bicycle Therapeutics
BCYC
$485M
| $7.12 | $40 |
462%
upside
| Buy |
15 Jul ‘21
4 years ago |
|
8
Ultragenyx Pharmaceutical
RARE
$3.04B
| $31.50 | $105 |
233%
upside
| Buy |
29 Oct ‘20
4 years ago |
|
9
Halozyme
HALO
$8.87B
| $76.07 | $27 |
65%
downside
| Buy |
19 May ‘20
5 years ago |
|
10
Neurogene
NGNE
$278M
| $19.25 | $400 |
1,978%
upside
| Buy |
12 Mar ‘20
5 years ago |
|
11
Black Diamond Therapeutics
BDTX
$174M
| $3.25 | $50 |
1,438%
upside
| Buy |
24 Feb ‘20
5 years ago |
|